Healthy thymus cuts cancer and cardiovascular death risk, study finds
Updated
Updated · 112.ua · May 3
Healthy thymus cuts cancer and cardiovascular death risk, study finds
10 articles · Updated · 112.ua · May 3
Nature researchers tracked 1,200 lung cancer immunotherapy patients and found a healthy thymus lowered metastasis risk by 37% and cancer death by 44%.
A second analysis of 25,000 screening participants and 2,500 healthy volunteers linked thymus health to 36% lower lung cancer risk and 63% lower cardiovascular mortality.
The findings strengthen earlier evidence that losing the thymus raises adult mortality and cancer risk, and could guide prevention, immune-boosting therapies and treatment strategies.
Since a healthy thymus boosts cancer therapy, how can patients actively improve their own treatment odds?
Is a shrinking thymus the cause of aging, or just a casualty of an unhealthy lifestyle?
Can we bioengineer a 'super-thymus' to halt aging and conquer diseases like cancer?
Preserving the Adult Thymus: Critical for Reducing Mortality and Enhancing Immune Therapy Success
Overview
In 2026, researchers developed an AI system that analyzes routine chest CT scans to generate a Thymic Health Score, which measures the body's immune competence. Higher scores are linked to significantly lower risks of death, cardiovascular disease, and lung cancer, and predict better outcomes for cancer patients receiving immunotherapy. The thymus remains vital in adults, producing T cells that protect against disease, while its removal or natural shrinkage leads to immune problems and higher cancer risk. Lifestyle changes like quitting smoking and exercise support thymic health, and new mRNA therapies show promise in regenerating thymic function, offering hope for improved immune resilience and personalized treatment.